Axos Financial, Inc. logo AX - Axos Financial, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 11
HOLD 8
SELL 0
STRONG
SELL
0
| PRICE TARGET: $124.50 DETAILS
HIGH: $128.00
LOW: $121.00
MEDIAN: $124.50
CONSENSUS: $124.50
UPSIDE: 28.76%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Moderate
Trading 23.5% below fair value
Current Price $96.69
Bear Case $88.42 8.6% downside ($88.42 - $96.69) / $96.69 = -8.6% ROTCE 13.4% → 1.33x TBV
Fair Value $126.31 30.6% upside ($126.31 - $96.69) / $96.69 = 30.6% ROTCE 17.9% → 1.96x TBV
Bull Case $164.20 69.8% upside ($164.20 - $96.69) / $96.69 = 69.8% ROTCE 20.5% → 2.34x TBV

Adjust Assumptions

17.9%
11.1%

Key Value Driver

ROTCE (17.9%) vs. cost of equity (11.1%)

Implied Market Multiple 2.0x

Plain-Language Summary

With ROTCE of 17.9% vs. 11.1% cost of equity, fair P/TBV is 1.96x on $48.29 tangible book, implying $126.31 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (20 analysts) $124.50
Analyst Range $121.00 – $128.00
Divergence from AlphaVal 1%

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly